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AbstrAct
Objectives
To examine the association between the Life Simple 7 
cardiovascular health score at age 50 and incidence of 
dementia.
Design
Prospective cohort study.
setting
Civil service departments in London (Whitehall II 
study; study inception 1985-88).
ParticiPants
7899 participants with data on the cardiovascular 
health score at age 50.
exPOsures
The cardiovascular health score included four 
behavioural (smoking, diet, physical activity, body mass 
index) and three biological (fasting glucose, blood 
cholesterol, blood pressure) metrics, coded on a three 
point scale (0, 1, 2). The cardiovascular health score was 
the sum of seven metrics (score range 0-14) and was 
categorised into poor (scores 0-6), intermediate (7-11), 
and optimal (12-14) cardiovascular health.
Main OutcOMe Measure
Incident dementia, identified through linkage to 
hospital, mental health services, and mortality 
registers until 2017.
results
347 incident cases of dementia were recorded over 
a median follow-up of 24.7 years. Compared with an 
incidence rate of dementia of 3.2 (95% confidence 
interval 2.5 to 4.0) per 1000 person years among 
the group with poor cardiovascular health, the 
absolute rate differences per 1000 person years 
were −1.5 (95% confidence interval −2.3 to −0.7) 
for the group with intermediate cardiovascular 
health and −1.9 (−2.8 to −1.1) for the group with 
optimal cardiovascular health. Higher cardiovascular 
health score was associated with a lower risk of 
dementia (hazard ratio 0.89 (0.85 to 0.95) per 1 point 
increment in the cardiovascular health score). Similar 
associations with dementia were observed for the 
behavioural and biological subscales (hazard ratios 
per 1 point increment in the subscores 0.87 (0.81 
to 0.93) and 0.91 (0.83 to 1.00), respectively). The 
association between cardiovascular health at age 50 
and dementia was also seen in people who remained 
free of cardiovascular disease over the follow-up 
(hazard ratio 0.89 (0.84 to 0.95) per 1 point increment 
in the cardiovascular health score).
cOnclusiOn
Adherence to the Life Simple 7 ideal cardiovascular 
health recommendations in midlife was associated 
with a lower risk of dementia later in life.
Introduction
Pathophysiological hallmarks of dementia appear 
15-20 years before clinical symptoms,1 highlighting 
the need for a long follow-up to identify risk factors 
and protective factors. Guidelines for prevention of 
dementia recommend targeting midlife cardiovascular 
risk factors.2 3 Much of the evidence is on individual 
cardiovascular risk factors considered one at a 
time, although the importance of their clustering is 
increasingly recognised. In 2010 the American Heart 
Association (AHA) proposed the ideal cardiovascular 
health score, also referred to as Life’s Simple 7, 
composed of four behavioural and three biological 
metrics for primordial prevention of cardiovascular 
disease.4 People with higher cardiovascular health 
scores have a lower risk of cardiometabolic diseases, 
such as type 2 diabetes, coronary heart disease, and 
stroke, than do those with lower scores.5 6
The cardiovascular health score has recently 
been put forward as a tool for the promotion of 
brain health.7 In studies on older populations, a 
higher cardiovascular health score has been shown 
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WhAt Is AlreAdy knoWn on thIs topIc
Dementia is a progressive multifactorial disease involving pathophysiological 
changes over a long preclinical period
The Life Simple 7 cardiovascular health score has been put forward as a potential 
tool for prevention of dementia, although evidence from observational studies 
remains inconsistent
An important source of inconsistency in the findings stems from the fact that 
most studies assess risk factors in late life and examine the onset of dementia 
over short follow-up periods
Findings are thus likely to be attributable to reverse causation due to changes in 
risk factor levels in the preclinical phase of dementia
WhAt thIs study Adds
Adherence at age 50 to the Life Simple 7 cardiovascular health 
recommendations, designed for the prevention of cardiovascular disease, might 
also decrease risk of dementia at older age
This association was also observed in people who remained free of 
cardiovascular disease over the follow-up
Reductions in risk of dementia were evident across the continuum of the 
cardiovascular health score, suggesting that even small improvements in 
cardiovascular risk factors are likely to be beneficial for cognitive health
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to be associated with slower cognitive decline and 
reduced risk of dementia,8 although the evidence is 
inconsistent across studies.9-11 An important source 
of uncertainty in the evidence is failure to consider 
the long preclinical period preceding the diagnosis 
of dementia.1 In studies with a short follow-up, risk 
factor levels might be affected by the preclinical phase 
of dementia, as shown for obesity and hypertension,12 
13 which are two of the seven metrics included in the 
cardiovascular health score.
Using data from the Whitehall II cohort study 
spanning nearly three decades, we aimed to investigate 
the association of cardiovascular health score assessed 
at age 50 with incidence of late life dementia; to assess 
whether cardiovascular health score at age 50 is 
associated with incidence of dementia in people who 
remain free of cardiovascular disease until diagnosis of 
dementia; and, in a subcohort of the Whitehall study, 
examine the association of cardiovascular health score 
at age 50 with brain volume assessed 20 years later 
using magnetic resonance imaging.
Methods
study population
The Whitehall II study is an ongoing cohort study of 
10 308 people (6895 men and 3413 women, aged 35-
55) recruited from the British civil service in 1985-88.14 
Baseline assessment consisted of a questionnaire and 
a structured clinical evaluation composed of measures 
of anthropometric, cardiovascular, and metabolic risk 
factors and diseases. Subsequent follow-up clinical 
examinations have taken place approximately every 
four to five years (1991, 1997, 2002, 2007, 2012, and 
2015), with each wave taking two years to complete. 
Written informed consent from participants was 
renewed at each contact.
Measures
Cardiovascular health at age 50
We used data collected at the first four clinical 
examinations of the study (1985 (age range 35-55 
years), 1991 (40-64 years), 1997 (45-69 years), and 
2002 (50-74 years)) to extract information on the 
seven cardiovascular health metrics at age 50 for every 
participant, allowing a five year margin either way.
Smoking status (current, past, never), physical 
activity (hours of moderate and vigorous physical 
activity per week), and diet (fruit and vegetable 
consumption, types of bread) were assessed using 
questionnaires. A trained nurse used standard 
protocols to collect data on body mass index (weight/
height2 in kg/m2), fasting glucose concentration, blood 
cholesterol concentration, and blood pressure during 
the clinical examination. Blood pressure was taken 
as the mean of two measurements using a Hawksley 
random zero sphygmomanometer (1985, 1991, 
and 1997) and OMRON HEM 907 (2002) with the 
participant in a sitting position after five minutes of 
rest. Weight was measured in underwear to the nearest 
0.1 kg on Soehnle electronic scales with digital readout 
(Leifheit, Nassau, Germany), and height was measured 
in bare feet to the nearest 1 mm by using a stadiometer 
with the participant standing erect with the head in 
the Frankfurt plane. Venous blood samples were taken 
after at least five hours of fasting, and serum obtained 
after centrifugation was refrigerated at 4°C and assayed 
within 72 hours of the blood draw. Total cholesterol 
was measured using a Cobas Fara centrifugal analyzer 
(Roche Diagnostics, Nutley, NJ).
We categorised all metrics into three levels (coded 
as poor=0, intermediate=1, and optimal=2), following 
the AHA’s recommendations,4 apart from smoking and 
diet, for which we adapted the categorisation to reflect 
data available in the study (table 1). For smoking, we 
split ex-smokers into optimal and intermediate levels 
depending on whether they had stopped smoking 
before or after the previous wave of data collection 
(corresponding to a four to five year gap, instead of 
one year). For the diet metric, we used information on 
consumption of fruit and vegetables and type of bread, 
as this information was available from all waves of 
data collection.
We used the sum of each metric to calculate the 
cardiovascular health score, ranging from 0 to 14 with 
higher scores corresponding to better cardiovascular 
health. We categorised this score as poor for scores 
ranging from 0 to 6 (corresponding to less than one 
standard deviation from the mean), intermediate 
for scores ranging from 7 to 11 (+/−1 SD from the 
mean), and optimal for scores between 12 and 14 
(>1 SD from the mean). We also derived the number 
of cardiovascular health metrics at optimal level, 
ranging from zero (none) to seven (all metrics at 
optimal level).
We calculated a behavioural score as the sum of the 
behavioural metrics (smoking, physical activity, diet, 
body mass index) ranging from 0 (worst) to 8 (best) and 
a biological score as the sum of the biological metrics 
(glucose, cholesterol, blood pressure) ranging from 0 
(worst) to 6 (best), as recommended by the AHA.4
Dementia
All residents in England, Scotland, and Wales have a 
unique National Health Service (NHS) identification 
number, which we used to link all participants to 
electronic health records. We used three registers (the 
national hospital episode statistics (HES) database, 
the Mental Health Services Data Set, and the mortality 
register) for ascertainment of dementia using ICD-10 
(international classification of disease, 10th revision) 
codes F00-F03, F05.1, G30, and G31. Record linkage 
was available until 31 March 2017. The NHS provides 
most of the healthcare, including outpatient and 
inpatient care. The sensitivity of dementia in the 
HES data is 78.0%, and the specificity is 92.0%.15 In 
addition, we used the Mental Health Services Data 
Set, a national database containing information on 
dementia for people in contact with mental health 
services in hospitals, outpatient clinics, and the 
community. Cause specific mortality data came from 
the British national mortality register (National Health 
Services Central Registry). Date of dementia was set at 
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the first record of diagnosis of dementia in any of the 
three databases used for ascertainment.
Cardiovascular disease
Coronary heart disease was identified by study specific 
assessments (12 lead resting electrocardiogram 
recording, coded using the Minnesota system), self 
reported coronary heart disease (verified in medical 
records), and linkage to HES (ICD-9 codes 410-414, 
ICD-10 codes I20-I25, or procedures K40–K49, K50, 
K75, U19). Stroke was determined using linkage to 
HES (ICD-9 430, 431, 434, 436; ICD-10 I60-I64).
Covariates
Covariates assessed at age 50 included exact age, sex, 
ethnicity (white, non-white), marital status (married/
cohabiting, other), and socioeconomic status according 
to occupational position (high, intermediate, and low, 
representing income and status at work) and education 
(less than primary school (up to age 11), lower 
secondary school (up to age 16), higher secondary 
school (up to age 18), university, and higher university 
degree). In sensitivity analysis, we also used data on 
apolipoprotein E ε4.
Brain volume
Between 2012 and 2016, a magnetic resonance 
imaging substudy was implemented in 771 
participants of the Whitehall II study. Details of the 
imaging protocol and the analysis pipelines have 
been published previously.16 In brief, multimodal 
magnetic resonance imaging scans were acquired 
at the Oxford Centre for Functional MRI of the Brain 
(FMRIB Centre) by using a 3-tesla magnetic resonance 
imaging scanner (MAGNETOM Verio; Siemens 
Healthineers, Erlangen, Germany) with a 32 channel 
head coil. Structural images were acquired using 
a high resolution, three dimensional, T1 weighted 
sequence (repetition time 2530 ms, echo time 7.37 
ms, flip angle 78 degrees, field of view 256 mm, 
voxel dimensions 1.0 mm isotropic). Data processing 
and analysis of magnetic resonance imaging was 
done using FMRIB Software Library (FMRIB, Oxford, 
UK). Brain tissues were segmented using FMRIB’s 
automated segmentation tool, which allows extraction 
of measures of total grey matter, white matter, and 
cerebrospinal fluid, which were summed to calculate 
intracranial volume. All volumes were normalised by 
converting them to percentages of the intracranial 
volume. Burden of white matter hyperintensities was 
estimated by using the Fazekas visual rating scale.17 A 
score (range 0-3) was assigned for deep white matter 
and periventricular areas depending on the size, 
location, and confluence of lesions. Total burden of 
white matter hyperintensities was estimated by using 
the sum of the two scores (range 0-6). Three clinicians 
independently defined hippocampal atrophy 
according to visual rating (Scheltens score,18 range 
0-8) and reached a consensus.
statistical analysis
Association of cardiovascular health at age 50 with 
incidence of dementia
We examined the association of cardiovascular 
health score at age 50 with risk of incident dementia 
by using Cox regression with date of entry being the 
date of clinical examination at age 50. We followed 
participants to the date of record of dementia, death 
(to account for competing risk of mortality), or 31 
March 2017, whichever came first. We first examined 
the shape of the association of the continuous 
cardiovascular health score with risk of dementia by 
using restricted cubic spline regressions with Harrell 
knots,19 Stata command xblc,20 with score 9 (mean 
cardiovascular health score) as the reference (hazard 
ratio=1). In addition, we examined the association 
with the cardiovascular health score categorised 
as poor (score 0-6), intermediate (score 7-11), and 
optimal (score 12-14) and then used cardiovascular 
health score as a linear variable to examine the 
risk reduction associated with a 1 point increment. 
We repeated the analysis for an increment of one 
additional cardiovascular health metric at the optimal 
level and for the behavioural and biological subscale 
scores. We used age as the timescale and adjusted 
analyses first for sex, ethnicity, educational level, 
occupational position, and marital status and then 
for time dependent cardiovascular disease. For the 
subsample with available data on apolipoprotein E ε4 
genotype, we also adjusted for this variable.
We used inverse probability weighting to account for 
missing data on cardiovascular health metrics.21 This 
involved calculation of the probability of being included 
in the analytical sample by using data on the seven 
table 1 | Definition of cardiovascular health metrics
Metrics Poor level (score=0) intermediate level (score=1) Optimal level (score=2)
Smoking Current smoker Stopped in past 5 years Never smoked or stopped >5 years ago
Diet Consumption of fruit and vegetable less than 
twice a day AND no consumption of high fibre 
bread
Consumption of fruit and vegetable twice a day or 
more Or consumption of high fibre bread
Consumption of fruit and vegetable twice a day or 
more AND consumption of high fibre bread
Physical activity No moderate or vigorous physical activity 1-149 min/week of moderate activity Or 1-74 
min/week of vigorous activity Or 1-149 min/
week of moderate and vigorous activity
≥150 min/week of moderate activity Or ≥75 min/
week of vigorous activity Or ≥150 min/week of 
moderate and vigorous activity
Body mass index ≥30 25-29.9 <25
Fasting glucose ≥126 mg/dL <100 mg/dL treated Or 100-125 mg/dL <100 mg/dL untreated
Blood cholesterol ≥240 mg/dL <200 mg/dL treated Or 200-239 mg/dL <200 mg/dL untreated
Systolic and diastolic 
blood pressure
SBP ≥140 mm Hg Or DBP ≥90 mm Hg SBP <120 mm Hg and DBP <80 mm Hg treated Or 
SBP 120-139 Or DBP 80-89 mm Hg
SBP <120 mm Hg and DBP <80 mm Hg untreated
DBP=diastolic blood pressure; SBP=systolic blood pressure.
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cardiovascular health metrics, sociodemographic 
factors, chronic conditions (coronary heart disease, 
stroke, diabetes, chronic obstructive pulmonary 
disease, cancer), and dementia status over the follow-
up, including the interactions between dementia 
status and the cardiovascular health metrics. We used 
the inverse of these probabilities to weight the results 
from the Cox regression.
Role of cardiovascular health score at age 50 in 
transitions between healthy state, cardiovascular 
disease, and dementia
In subsequent analyses, we used multi-state models to 
examine the role of cardiovascular disease (incident 
coronary heart disease or stroke) over the follow-up 
in the association between cardiovascular health 
score at age 50 and risk of dementia. These models 
allow simultaneous estimation of the association 
of cardiovascular health score at age 50 with risk of 
cardiovascular disease over the follow-up (transition 
A), the association of cardiovascular health score 
at age 50 with risk of dementia in people without 
cardiovascular disease over the follow-up (transition 
B), and the association of cardiovascular health 
score at age 50 with risk of dementia following 
diagnosis of cardiovascular disease (transition C). As 
in the previous analyses, models were adjusted for 
sociodemographic factors and weighted using inverse 
probability weighting.
Association between cardiovascular health score 
and brain volume
In the magnetic resonance imaging analysis, we 
examined the association of cardiovascular health at 
age 50 with whole brain volume (sum of grey and white 
matter), grey matter volume, and white matter volume, 
as well as with levels of white matter hyperintensities 
and hippocampal atrophy on average 20 years later by 
using linear regression adjusted for age at magnetic 
resonance imaging assessment, the magnetic 
resonance imaging scanner, and sociodemographic 
factors at age 50.
We ran the multi-state models by using the “mstate” 
package of R software. For all other analyses, we used 
Stata 15.1. We rejected the null hypothesis for two 
sided values of P<0.05.
Patient and public involvement
Participants of the Whitehall II study were not involved 
in setting the research question or the outcome 
measures, nor were they involved in developing plans 
for recruitment, design, or implementation of the study. 
No participants were asked for advice on interpretation 
or writing up of results. However, all results are 
disseminated to study participants via newsletters 
and our website, which has a participant portal 
(https://www.ucl.ac.uk/epidemiology-health-care/
research/epidemiology-and-public-health/research/
whitehall-ii/participants-area). The dissemination 
plan targets a large audience, including members of 
the public, patients, and health professionals, and 
will be achieved through various channels, including 
media outreach via press release from the Inserm 
and University College London, networks, and social 
media.
results
Among the 9740 participants free of cardiovascular 
disease and dementia at age 50 (target population), 
data on all cardiovascular health metrics at age 50 
(mean age at assessment 50.4 (SD 2.3) years) were 
available for 7899 participants (fig 1). Compared with 
those not included in the analysis (n=1841), study 
participants were older at baseline (45.3 v 41.6 years) 
and were more likely to be men (67.6% (n=5337) 
v 64.2% (n=1182)) and to develop dementia over 
the follow-up period (4.4% (n=347) v 3.3% (n=61)) 
(all P<0.05), leading us to use inverse probability 
weighting to take these differences into account in the 
analyses.
Among the 7899 study participants, a total of 347 
cases of dementia were recorded over a median follow-
up of 24.7 (interquartile range 19.1-29.3) years. 
Mean age at diagnosis of dementia was 75.3 (SD 5.3; 
interquartile range 72.3-79.4) years. Table 2 shows 
characteristics of the study sample at age 50. The 
proportion of women, non-white participants, and 
participants in the lower socioeconomic group was 
higher in the group of dementia cases compared with 
participants who did not develop dementia during 
follow-up. Participants with higher cardiovascular 
health score, denoting better health, were more likely 
to be male, white, married/cohabiting, and from the 
higher educational and occupational groups. Further 
distribution of the cardiovascular health metrics and 
by categories of the cardiovascular health score are 
shown in supplementary table A.
association of cardiovascular health score at age 50 
with incidence of dementia
As we found no evidence of effect modification by 
sex (P for interaction=0.42), we did analyses in men 
and women combined, with adjustment for sex. 
We verified the proportional hazard assumption by 
using Schoenfeld residuals and Kaplan-Meier curves 
(supplementary figure A). Figure 2 shows the association 
between the 14 point cardiovascular health score and 
risk of dementia to be linear (P for non-linearity=0.26). 
Further analyses using cardiovascular health score 
categorised in three groups showed the incidence 
rate of dementia to be lower in the intermediate and 
optimal cardiovascular health groups than in the poor 
cardiovascular health group (table 3). Compared with 
an incidence rate of dementia of 3.2 (95% confidence 
interval 2.5 to 4.0) per 1000 person years among the 
group with poor cardiovascular health (scores 0-6), the 
absolute rate differences per 1000 person years were 
−1.5 (95% confidence interval −2.3 to −0.7) for the 
group with intermediate (7-11) and −1.9 (−2.8 to −1.1) 
for the group with optimal (12-14) cardiovascular 
health. In an analysis adjusted for sociodemographic 
factors, compared with the poor cardiovascular 
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health category, intermediate and optimal categories 
of cardiovascular health were associated with lower 
risk of dementia (hazard ratio 0.61 (0.47 to 0.80) and 
0.57 (0.36 to 0.90), respectively; table 3). The hazard 
ratio for dementia for an increment of 1 point in the 
cardiovascular health score was 0.89 (0.85 to 0.95). 
Additional adjustment for cardiovascular disease 
as a time varying variable slightly attenuated this 
association (hazard ratio 0.91 (0.86 to 0.97) per 1 
point increment in the cardiovascular health score).
In an analysis using the seven cardiovascular 
health metrics at optimal levels, and adjusted for 
sociodemographic factors, the hazard ratio for dementia 
for each additional metric at optimal level was 0.88 
(0.79 to 0.97). Both the behavioural and biological 
subscale scores were associated with incidence of 
dementia (hazard ratio per 1 point increment 0.87 
(0.81 to 0.93) and 0.91 (0.83 to 1.00), respectively), 
and we found no evidence of an interaction between the 
two (P=0.32). On further analysis in 4996 participants 
with relevant data available, results remained similar 
after additional adjustment for apolipoprotein E ε4 
(supplementary table B).
role of cardiovascular health score at age 50 in 
transitions between healthy state, cardiovascular 
disease, and dementia
Before use of multi-state modelling transitions between 
health states, we examined the association between 
cardiovascular disease and incidence of dementia. As 
expected, cardiovascular disease was associated with 
a higher risk of incident dementia (hazard ratio 1.96, 
1.56 to 2.48) in a Cox regression with cardiovascular 
disease treated as a time dependent variable (data 
not tabulated). Figure 3 shows results from multi-
state models in participants free of dementia and 
cardiovascular disease at age 50 (n=7899). A 1 
point increment in the cardiovascular health score 
was associated with a reduced risk of incident 
cardiovascular disease over the follow-up (transition 
A: hazard ratio 0.87, 0.85 to 0.89). Among people free 
of cardiovascular disease before diagnosis of dementia, 
a 1 point increment in cardiovascular health score was 
associated with a lower risk of dementia (transition 
B: hazard ratio 0.89, 0.84 to 0.95), suggesting that 
the association between cardiovascular health and 
dementia is not fully explained by clinically manifest 
cardiovascular disease. In those with cardiovascular 
disease over the follow-up, cardiovascular health score 
at age 50 was not associated with risk of dementia 
following diagnosis of cardiovascular disease 
(transition C: hazard ratio 0.98, 0.91 to 1.06).
Study recruitment, age 35-55, 1985-88
Excluded
Age ≥55 at recruitment
Died before age 45
Prevalent cardiovascular disease cases
Prevalent dementia cases
344
24
200
0
10 308
Target population, age 45-54.9, between 1985-88 and 2015-16
568
Missing data
Cardiovascular health metrics
Covariates
973
43
Did not participate in waves when age 45-54.9
825
1016
9740
Participants in at least one wave age 45-54.9
8915
End of follow-up 31 August 2017
7899
Fig 1 | Flowchart of sample selection
table 2 | sample characteristics at age 50 (n=7899). values are numbers (percentages) unless stated otherwise
characteristics
cardiovascular health score at age 50
P value
Dementia status at end of follow-up
P value
Poor  
(0-6; n=978)
intermediate  
(7-11; n=5997)
Optimal  
(12-14; n=924)
no dementia  
(n=7552)
Dementia  
(n=347)
Sex:
<0.001 <0.001 Men 578 (59.1) 4119 (68.7) 640 (69.3) 5143 (68.1) 194 (55.9)
 Women 400 (40.9) 1878 (31.3) 284 (30.7) 2409 (31.9) 153 (44.1)
Ethnicity:
<0.001 <0.001 White 823 (84.1) 5408 (90.2) 884 (95.7) 6823 (90.3) 292 (84.1)
 Non-white 155 (15.8) 589 (9.8) 40 (4.3) 729 (9.7) 55 (15.9)
Education:
<0.001 <0.001
 Less than primary school 137 (14.0) 633 (10.6) 67 (7.3) 776 (10.3) 61 (17.6)
 Lower secondary school 459 (46.9) 2185 (36.4) 257 (27.8) 2751 (36.4) 150 (43.2)
 Higher secondary school 227 (23.2) 1586 (26.4) 232 (25.1) 1977 (26.2) 68 (19.6)
 University 116 (11.9) 1226 (20.4) 266 (28.8) 1560 (20.7) 48 (13.8)
 Higher university degree 39 (4.0) 367 (6.1) 102 (11.0) 488 (6.5) 20 (5.8)
Occupational position:
<0.001 <0.001 Low 343 (35.1) 1091 (18.2) 78 (8.4) 1378 (18.2) 134 (38.6) Intermediate 417 (42.6) 2620 (43.7) 372 (40.3) 3283 (43.5) 126 (36.3)
 High 218 (22.3) 2286 (38.1) 474 (51.3) 2891 (38.3) 87 (25.1)
Married/cohabiting:
<0.001 0.10 No 295 (30.2) 1430 (23.8) 214 (23.2) 1841 (24.4) 98 (28.2)
 Yes 683 (69.8) 4567 (76.2) 710 (76.8) 5711 (75.6) 249 (71.8)
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association of cardiovascular health at age 50 with 
brain volume 20 years later
Among 771 participants who had magnetic resonance 
imaging assessment, data on cardiovascular health 
at age 50 were available for 708 participants (569 
(80.4%) men, mean age at assessment 69.9 (SD 5.1) 
years). One year higher age was associated with 0.33% 
(95% confidence interval 0.30% to 0.36%) lower whole 
brain volume, 0.25% (0.22% to 0.28%) lower grey 
matter volume, 0.08% (0.06% to 0.10%) lower white 
matter volume, 0.09 (0.07 to 0.10) points higher white 
matter hyperintensities on the Fazekas scale, and 0.11 
(0.09 to 0.13) points greater hippocampal atrophy on 
the Scheltens score. Higher cardiovascular health score 
(per 1 point increment in the cardiovascular health 
score) was associated with 0.14% (0.06% to 0.22%) 
higher total brain and 0.12% (0.06% to 0.19%) higher 
grey matter volumes (table 4), corresponding to an age 
effect of 5.1 months on whole brain volume and 5.8 
months on grey matter volume. Higher cardiovascular 
health score was associated with lower hippocampal 
atrophy, but the results did not reach statistical 
significance (P=0.07).
discussion
This longitudinal study based on 7899 men and 
women has three key findings. Firstly, the American 
Heart Association’s cardiovascular health score 
assessed at age 50 was associated with subsequent 
risk of dementia over a 24.7 year median follow-up 
period, with lower risk observed for both intermediate 
and optimal scores compared with poor scores. 
The associations were evident for the continuous 
cardiovascular health score as well as the behavioural 
and biological scores, suggesting that both these 
subscales contribute to dementia risk. Secondly, the 
association between cardiovascular health at age 50 
and subsequent dementia was also observed among 
people without coronary heart disease or stroke during 
the follow-up period. Thus, cardiovascular disease 
events do not fully account for the association between 
cardiovascular health and dementia. Thirdly, findings 
were corroborated in results using magnetic resonance 
imaging data for a subcohort. Higher cardiovascular 
health score at age 50 was associated with higher 
whole brain and grey matter volumes 20 years later.
strengths and limitations of study
We assessed cardiovascular health close to age 50 
(mean age 50.4 (SD 2.3) years, age range 45-55). 
Much of the previous evidence on “midlife” risk 
factors has used a wide age range, sometimes as 
large as 20 years, from a baseline assessment to draw 
conclusions on the importance of midlife factors. This 
is particularly problematic for research on dementia, 
as risk factor levels change during the long preclinical 
period of dementia,1 which can lead to findings that 
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Fig 2 | association between continuous 14 point cardiovascular health score and 
incidence of dementia. Hazard ratio (95% ci) was estimated using inverse probability 
weighted cox regression model with age as timescale and adjusted for sex, ethnicity, 
education, occupational position, and marital status, with a score of 9 (mean) as 
reference (hazard ratio=1)
table 3 | cardiovascular health score and incidence of dementia (median follow-up 24.7 (interquartile range 19.1-29.3) years)
no of cases/total no
incidence rate (95% ci) 
per 1000 person years
Hazard ratio (95% ci) for 
dementia: model 1* P value
Hazard ratio for dementia 
(95% ci): model 1+cvD† P value
cardiovascular health score
Poor (0-6) 71/978 3.2 (2.5 to 4.0) 1 (reference) 1 (reference)
Intermediate (7-11) 249/5997 1.8 (1.5 to 2.0) 0.61 (0.47 to 0.80) <0.001 0.67 (0.51 to 0.88) 0.004
Optimal (12-14) 27/924 1.3 (0.8 to 1.8) 0.57 (0.36 to 0.90) 0.02 0.65 (0.41 to 1.03) 0.06
1 point increment in CVH score  
(range 0-14) 347/7899 1.9 (1.7 to 2.1) 0.89 (0.85 to 0.95) <0.001 0.91 (0.86 to 0.97) 0.001
Each additional CVH metric at optimal level 
(range 0-7) 347/7899 1.9 (1.7 to 2.1) 0.88 (0.79 to 0.97) 0.01 0.90 (0.81 to 0.99) 0.04
cardiovascular health subscales
1 point increment in behavioural scale 
(range 0-8) 347/7899 1.9 (1.7 to 2.1) 0.87 (0.81 to 0.93) <0.001 0.89 (0.82 to 0.95) 0.001
1-point increment in biological scale (range 
0-6) 347/7899 1.9 (1.7 to 2.1) 0.91 (0.83 to 1.00) 0.06 0.94 (0.86 to 1.04) 0.24
CVD=cardiovascular disease; CVH=cardiovascular health.
*Hazard ratio estimated using inverse probability weighted Cox regression models with age as timescale and adjusted for sex, ethnicity, education, occupational position, and marital status 
(model 1).
†Model 1, additionally adjusted for time dependent cardiovascular disease.
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are affected by reverse causation.12 13 22 Key strengths 
of this study include use of a study design that 
allowed us to assess cardiovascular health metrics at 
age 50, a long follow-up for incidence of dementia, 
the use of multiple statistical methods to control 
for bias and confounding,21 and inclusion of data 
from the Whitehall II magnetic resonance imaging 
substudy.
A key limitation, as in any observational study, is 
the self reported measure of behavioural factors and 
drug use. The Whitehall II study is an occupational 
cohort at recruitment, and participants are healthier 
than the general population in terms of risk factors 
levels and incidence of disease. However, this does not 
necessarily affect risk factor-disease associations.23 
For example, the association between cardiovascular 
risk factors and incidence of cardiovascular disease 
in the Whitehall II study is similar to that in general 
population studies.24
Use of linkage to electronic health records for 
ascertainment of dementia may not be the “gold 
standard” method but has the advantage of allowing 
analysis on everyone recruited to the study rather than 
only those who continue to participate over the course 
of the study and are available for an in-person clinical 
ascertainment of dementia. In the UK, HES records on 
dementia have been shown to have high specificity 
but modest sensitivity (78%) due to missing of milder 
cases of dementia,15 as also reported in the Mayo Clinic 
Study of Ageing and the Adult Changes study.25 We 
additionally used the UK mental health database to 
improve the sensitivity of dementia diagnosis.26
comparison with previous studies
Few previous studies have examined the association 
between cardiovascular health and cognitive 
outcomes, and most were based on older adults who 
were followed for cognitive outcomes for less than 10 
years. These studies reported better cardiovascular 
health to be associated with lower risk of cognitive 
impairment,27 cognitive decline,8 9 and dementia.8  10 
In the Atherosclerosis Risk in Community (ARIC) 
cohort, higher cardiovascular health scores assessed at 
mean age 54 (SD 6) years were associated with slower 
cognitive decline over a 20 year follow-up period.28 
In participants from the Framingham Heart Study 
Offspring cohort, the association with risk of dementia 
was observed when risk factors were assessed at a 
mean age of 62 (SD 6) years but not when assessed at 
a mean age of 69 (6) years.10 In a study on people with 
a mean age of 67 (8) years at cardiovascular health 
assessment, no association was found with incidence 
of dementia over a seven year mean follow-up.11 One 
explanation for this inconsistency is that studies that 
assess risk factors at older ages are more likely to be 
affected by reverse causation bias than are those with 
this assessment in midlife, a possible explanation 
for null findings in recent studies on cardiovascular 
health and dementia.10 11 Evidence shows that the 
associations of body mass index, blood pressure, 
and cholesterol with dementia are attenuated or even 
reversed at older ages.11-13 29-31
Few studies, mostly cross sectional, have 
examined the association between cardiovascular 
health and brain imaging.10 26 32 33 Cardiovascular 
health has been shown to be associated with whole 
brain volume,10  32 although findings on specific 
markers are less consistent.10 26 32 33 White matter 
hyperintensities, particularly in the deep white matter, 
are usually interpreted as “microvascular changes” 
that are associated with vascular risk in general.34 
We found no association with cardiovascular health, 
which is consistent with some but not all previous 
studies.10 32 33 35 The large heterogeneity in population 
settings (mean age ranged from young adulthood 
to older age), as well as the type of brain imaging 
analysis, might explain inconsistent findings. Further 
investigations are thus needed to confirm specific 
brain correlates of cardiovascular health.
Meaning of study
The AHA’s recently defined concept of “ideal 
cardiovascular health” by presence of all seven metrics 
at an ideal level is useful for the primordial prevention 
of cardiovascular disease, as shown in several studies.5 
In our data, each additional cardiovascular health 
metric at optimal level was more strongly associated 
with a lower risk of cardiovascular diseases than 
was a 1 point increment in the more refined 14 point 
cardiovascular health score (fig 3, transition A). As a 
similar tool does not exist for dementia, we used the 
Start of follow-up
(free of cardiovascular
disease and dementia)
Dementia
Cardiovascular
disease
Transition A
HR = 0.83 (0.80 to 0.86)
Transition B
HR = 0.99 (0.85 to 1.14)
Transition C
HR = 0.89 (0.80 to 0.99)
Start of follow-up
(free of cardiovascular
disease and dementia)
Dementia
Cardiovascular
disease
Transition A
HR = 0.87 (0.85 to 0.89)
Hazard ratio per each additional CVH metric at optimal level
Hazard ratio per 1 point increment in CVH score
Transition B
HR = 0.98 (0.91 to 1.06)
Transition C
HR = 0.89 (0.84 to 0.95)
Fig 3 | Multi-state models for role of cardiovascular health (cvH) score in transitions 
between start of follow-up, cardiovascular disease, and dementia. top: hazard ratio 
(Hr) per 1 point increment in cvH score. bottom: Hr per each additional cvH metric at 
optimal level (range 0-7). Hrs and 95% cis were estimated using inverse probability 
weighted multi-state models with age as timescale and adjusted for sex, ethnicity, 
education, occupational position, and marital status. no of cardiovascular disease 
(cvD; coronary heart disease or stroke) cases among healthy participants=1570/7899 
(transition a); no of dementia cases among healthy participants=222/7899 (transition 
b); no of dementia cases among participants with cvD over follow-up=125/1570 
(transition c)
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cardiovascular health metrics at an optimal level and 
the 14 point cardiovascular health score.
Our results showed reductions in the risk of dementia 
across the continuum of the 14 point cardiovascular 
health score, highlighting the importance of clustering 
of cardiovascular risk factors in midlife for risk of 
dementia at older ages. Each 1 point increment in the 
14 point cardiovascular health score was associated 
with a similar reduction in the risk of dementia to 
each additional cardiovascular health metric at an 
optimal level (seven metrics). Use of a finely graded 
14 point scale, which also considers each metric 
at an intermediate level, suggests that even small 
improvements in cardiovascular health metrics, 
without necessarily reaching the optimal level for each 
metric, are likely to be beneficial in reducing the risk 
of dementia. From a public health perspective, moving 
from a poor to an intermediate level in cardiovascular 
health metrics is perhaps more achievable and 
sustainable in the long term than moving from a poor 
to an optimal level. In addition, both the behavioural 
and biological subscales of the cardiovascular 
health score were associated with incidence of 
dementia, and the absence of an interaction between 
the two subscales highlights the importance of 
the behavioural score at all levels of the biological 
subscale, including among people without biological 
risk factors at age 50. Dementia has a multifactorial 
aetiology, and accordingly multidomain interventions 
targeting several risk factors simultaneously have 
been recommended for prevention.36 Although the 
cardiovascular health metrics were not originally 
developed for the prevention of dementia, results from 
this observational study suggest that their assessment 
in midlife could be used for identification of groups 
at increased risk of dementia and that interventions 
targeting cardiovascular risk factors in midlife might 
additionally decrease the risk of dementia.37
Use of multi-state models in this study showed a 
robust association between cardiovascular health 
and incidence of dementia in participants free of 
major cardiovascular disease over the follow-up. 
Possible mechanisms by which cardiovascular health 
is associated with risk of dementia therefore include 
mechanisms beyond occlusion of major arteries, 
such as cerebral small vessel lesions, hypoxia, 
microinfarctions, inflammation, oxidative stress, 
and advanced glycation end products.37 The precise 
pathway through which vascular and degenerative 
processes determine risk of Alzheimer’s disease 
and dementia is likely to be complex. Our results 
showing cardiovascular health assessed at age 50 
to be associated with dementia and brain volume 20 
years later are in agreement with previous studies 
based on shorter follow-up.10 33 These results highlight 
the importance of the cardiovascular health score in 
promoting brain health at older ages.
conclusion
Prevention is an important element in tackling the 
challenge posed by the expected tripling of dementia 
cases by 2050. Our findings suggest that the Life’s 
Simple 7, which comprises the cardiovascular health 
score, at age 50 may shape the risk of dementia in a 
synergistic manner. Cardiovascular risk factors are 
modifiable, making them strategically important 
prevention targets. This study supports public health 
policies to improve cardiovascular health as early as 
age 50 to promote cognitive health.
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